Literature DB >> 7760196

Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

S Juvela1.   

Abstract

This follow-up study was designed to evaluate whether the use of aspirin either before or after aneurysm rupture affects the occurrence of delayed cerebral ischemia. Aspirin inhibits platelet function and thromboxane production and has been shown to reduce the risk of various cardiovascular and cerebrovascular ischemic diseases. Following admission, the patients in this study was interviewed regarding their use of aspirin and other medicines prior to and after hemorrhage, and their urine was screened qualitatively for salicylates. Patient outcome and the occurrence of hypodense lesions consistent with cerebral infarction on follow-up computerized tomography (CT) were studied prospectively up to 1 year after hemorrhage. Of 291 patients, 31 (11%) died because of the initial hemorrhage and 18 (6%) died due to rebleeding within 4 days after hemorrhage. Of the remaining 242 patients, 90 (37%) had delayed cerebral ischemia, which caused a permanent neurological deficit or death in 54 patients (22%). Of 195 patients undergoing follow-up CT, 85 (44%) had cerebral infarction that was not seen on the CT scan obtained on admission. Those who had salicylates in the urine on admission had a relative risk of 0.40 (95% confidence interval (CI), 0.15 to 1.10) of delayed ischemia with fixed deficit and a risk of 0.40 (95% CI, 0.18 to 0.93) of cerebral infarction compared with patients who did not have salicylates in their urine. This reduced risk of ischemic complications with aspirin use was restricted to those patients who used aspirin before hemorrhage, when the risk of ischemia was 0.21 (95% CI, 0.03 to 1.63) and the risk of infarct was 0.18 (95% CI, 0.04 to 0.84) compared with those who had not used aspirin. The reduced risk of cerebral infarction remained significant after adjustment for several potential confounding factors (adjusted risk 0.19; 95% CI, 0.04 to 0.89). These observations suggest that platelet function at the time of subarachnoid hemorrhage may be associated with delayed cerebral ischemia after aneurysm rupture.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7760196     DOI: 10.3171/jns.1995.82.6.0945

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

1.  Subarachnoid Hemorrhage.

Authors:  K D Flemming; R D Brown; D O Wiebers
Journal:  Curr Treat Options Neurol       Date:  1999-05       Impact factor: 3.598

2.  Antiplatelet Therapy in Patients with Aneurysmal SAH: Impact on Delayed Cerebral Ischemia and Clinical Outcome. A Meta-Analysis.

Authors:  F Cagnazzo; I Derraz; P-H Lefevre; G Gascou; C Dargazanli; C Riquelme; P Perrini; D di Carlo; A Bonafe; V Costalat
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-06       Impact factor: 3.825

Review 3.  Treatment options for cerebral vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  M Kamran Athar; Joshua M Levine
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 4.  Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.

Authors:  Daniel Naranjo; Michal Arkuszewski; Wojciech Rudzinski; Elias R Melhem; Jaroslaw Krejza
Journal:  Neuroradiol J       Date:  2013-12-18

5.  In vitro analysis of platelet function in acute aneurysmal subarachnoid haemorrhage.

Authors:  Christian von der Brelie; Alexander Subai; Verena Limperger; Veit Rohde; Astrid Dempfle; Azize Boström
Journal:  Neurosurg Rev       Date:  2017-07-24       Impact factor: 3.042

Review 6.  Prevention and treatment of thromboembolism during endovascular aneurysm therapy.

Authors:  Jens Fiehler; Thorsten Ries
Journal:  Klin Neuroradiol       Date:  2009-05-15

7.  Predictors and outcome of acute symptomatic cerebral infarctions following aneurysmal subarachnoid hemorrhage.

Authors:  Feng-Wen Su; Yu-Jun Lin; Wen-Neng Chang; Jih-Tsun Ho; Hung-Chen Wang; Tzu-Ming Yang; Thung-Ming Su; Wei-Che Lin; Nai-Wen Tsai; Yu-Ling Ding; Cheng-Hsien Lu
Journal:  J Neurol       Date:  2009-09-15       Impact factor: 4.849

8.  Recurrent perimesencephalic subarachnoid hemorrhage during antithrombotic therapy.

Authors:  H Bart van der Worp; Susanne Fonville; Lino M P Ramos; Gabriël J E Rinkel
Journal:  Neurocrit Care       Date:  2008-10-30       Impact factor: 3.210

9.  Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics.

Authors:  Melanie D King; Melissa D Laird; Sangeetha Sukumari Ramesh; Patrick Youssef; Basheer Shakir; John R Vender; Cargill H Alleyne; Krishnan M Dhandapani
Journal:  Neurosurg Focus       Date:  2010-01       Impact factor: 4.047

Review 10.  Antiplatelet therapy for aneurysmal subarachnoid haemorrhage.

Authors:  S M Dorhout Mees; W M van den Bergh; A Algra; G J E Rinkel
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.